Condition
Germline Mutation
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Unknown1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07019155RecruitingPrimary
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
NCT03857594Active Not Recruiting
Integrative Sequencing In Germline and Hereditary Tumours
NCT07204392Recruiting
Unveiling the Germline Predisposition to Myeloproliferative Neoplasms
NCT03092128Unknown
A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment
Showing all 4 trials